Premarket movers: Oracle surges on AI growth, ACV auctions jumps on $1.9B deal

Oracle shares rose 6.3% premarket after FQ1 2027 revenue increased 30% year over year to $19.35B and adjusted EPS reached $1.92, above the $1.73-$1.75 consensus range. Cloud infrastructure revenue surged 121% to $7.4B, GPU utilization was 97.9%, and Oracle booked roughly $30B of new AI-related contracts while raising FY2027 revenue guidance to more than $90B. Separately, Copart agreed to acquire ACV Auctions for approximately $1.9B in cash, sending ACV shares up 43.6%, while Adobe fell 2.8% on softer-than-expected Q4 revenue guidance despite a modest Q3 beat.

Analysis

ORCL’s re-rating hinges less on headline cloud growth than on whether contracted AI demand converts into durable, high-margin consumption revenue before the associated data-center build depresses free cash flow. Near-full GPU utilization gives Oracle unusual pricing power in the next 1-3 quarters, but it also makes capacity additions the binding constraint; Nvidia (NVDA), networking vendors (ANET) and power/cooling suppliers should see a secondary demand benefit. The key risk is customer concentration and contract quality: large AI commitments can inflate remaining performance obligations well ahead of recognized revenue, while lease and capex obligations can make the equity more rate-sensitive than traditional software peers.

ADBE’s setup is materially different: a modest guide shortfall during a CEO transition invites a multiple reset because investors need evidence that generative AI is expanding net retention rather than cannibalizing Creative Cloud pricing. The near-term issue is not one quarter of revenue, but whether enterprise digital-experience budgets are being redirected toward hyperscaler AI stacks and Salesforce (CRM). ADBE can recover over 6-12 months if paid AI attach rates and digital-experience bookings accelerate; absent that, estimate cuts are likely to compound as leadership uncertainty raises the required valuation discount.

CPRT’s acquisition creates a strategic fork in auto remarketing. Owning ACVA adds dealer-channel inventory and digital marketplace capability, but the purchase only earns a premium multiple if Copart can lift ACVA unit economics without triggering dealer or insurer pushback; the initial earnings dilution and integration costs could cap CPRT for 1-2 quarters. ACVA’s cash consideration removes fundamental upside for holders, leaving only closing-risk exposure. CHWY remains a macro-sensitive short/watch: weaker premiumization pressures gross-margin expansion precisely when fulfillment and marketing costs are relatively fixed, making consensus EBITDA assumptions vulnerable if discretionary demand does not improve.

Contrarian view: ORCL’s move may be underestimating the infrastructure bottleneck, but could be overestimating incremental equity value if financing needs rise faster than cloud gross profit. The most useful falsifier is the next earnings release: cloud growth must remain above 80% while operating cash flow and capex-to-revenue stabilize; otherwise the market will treat the AI backlog as capital-intensive revenue rather than software-like earnings power.

Key Decisions for Investors

• Initiate a 1-3 month long ORCL / short ADBE pair, sized beta-neutral. The trade isolates infrastructure AI monetization from application-software AI uncertainty; target 10-15% relative outperformance. Exit if ORCL cloud growth falls below 80%, management signals materially higher capex without a cash-flow bridge, or ADBE reports accelerating paid-AI adoption and raises FY guidance.
• Add a small NVDA or ANET satellite long against ORCL exposure over the next 1-2 quarters, preferably on post-earnings volatility pullbacks. Oracle’s capacity constraint should translate into orders upstream before its own revenue recognition; risk is a sharp reduction in hyperscaler/Oracle capex plans or easing GPU utilization below roughly 90%.
• For ACVA holders, tender/exit near the $10.50 cash consideration rather than retain unhedged exposure; only run a merger-arbitrage position after confirming regulatory timetable, financing terms and the annualized spread. The upside is mechanically capped, while antitrust review, closing delay, or a deal break creates asymmetric downside.
• Maintain CPRT as a watch rather than chase the initial move. Consider a 3-6 month long only if management quantifies revenue synergies and maintains core salvage-auction margins; otherwise, a failed integration could make CPRT underperform KAR and broader industrials despite strategic logic.
• Maintain a tactical short bias in CHWY for the next two reporting cycles only if sell-side EBITDA estimates remain unchanged despite weak discretionary trends. Cover on evidence of improving active-customer growth, sustained autoship expansion, or gross-margin improvement sufficient to offset fulfillment deleverage.